Eli Lilly & Co. (NYSE:LLY)

investor research

Top Analyst Upgrades and Downgrades: Apple, Intel, Chevron, Exxon, Qualcomm, Citigroup and More

Stocks are hitting new highs ahead of Friday's payrolls report, and investors are looking for upside while wanting to not get caught in the next sell-off. 24/7 Wall St. reviews ...
Read Full Story »
investing

Piper Jaffray Stocks to Buy for S&P 500 Going to 2,100

As the bull market enters its sixth year, the S&P 500 continues to set new highs and intermediate-term measures of market strength have turned positive since February. The old Wall ...
Read Full Story »
Pills

Four Upcoming Catalysts That Could Move Pharmaceutical Stocks

Wall Street firms are famous for their ability to throw conference after conference, year after year. Some are highly respected, and a must-attend for investment firms and portfolio managers. Others ...
Read Full Story »
health care

Merrill Lynch’s Top Health Care Stocks to Buy Now

Very quietly, while momentum stocks zoom up and down, one sector has made an almost stealth like move and is leading the S&P 500 so far this year. With the ...
Read Full Story »
investing

Six New Stocks to Buy in the Piper Jaffray Model Portfolio

Most Wall Street firms run model portfolios for their institutional and retail clients. Like all portfolios, they make weighting changes based on a variety of specifics that can include everything ...
Read Full Story »
biotech

Biotech Buyout Bolsters Novartis Cancer Portfolio

Pharmaceutical giant Novartis A.G. (NYSE: NVS) announced Monday morning that it will acquire startup biotech CoStim Pharmaceuticals. Terms of the deal were not revealed, but it will bolster Novartis's cancer ...
Read Full Story »
biotech

Top Pharma and Biotech Stocks to Buy From Key Investor Conference

The Leerink Global Healthcare conference is in full swing, and the reports coming out highlight what some top analysts on Wall Street already suspected. The rich are getting richer. With ...
Read Full Story »
rumors

Ariad Joins Rumor Mill: Hope May Trump Reality

Ariad Pharmaceuticals Inc. (NASDAQ: ARIA) is joining the ranks of the next big biotech acquisitions. At least so goes the rumor mill. Ariad fits the bill of many biotech acquirers ...
Read Full Story »
gavel

Teva Secures Rights to Launch Generic Viagra

Pfizer Inc.'s (NYSE: PFE) patent protecting popular erectile dysfunction drug Viagra from generic competition may not expire until April 2020, but Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) has acquired rights to ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Twitter, Best Buy, Exxon and More

Now that we are mostly through earnings season and now that stocks have challenged all-time highs recently, investors and traders alike have to start thinking about how to position themselves ...
Read Full Story »
Deere Logo

Stocks to Sell or Short: The Seven Least Preferred Stocks at UBS

UBS has a list of stocks that investors may want to consider selling. They could even be a list of short sale candidates. The UBS team is bashing Apache Corp. ...
Read Full Story »
AOL logo

Merrill Lynch Top America’s Edge Stocks to Buy and Sell for the Fourth Quarter

Heading into the fourth quarter of this year, investors who have been long the stock market are poised for the best gains since the market exploded off the lows in ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Corning, Intel, Merck, Micron and More

A new earnings season has started, and stocks and bonds are dealing with a likely patch for the government shutdown and the debt ceiling. So which are the stocks to ...
Read Full Story »
Pills

Credit Suisse Major Drug Stocks to Buy for Great Gains Ahead

The drug and pharmaceutical sector is supposed to be a defensive one by nature, even if this week's government shutdown and impending debt ceiling weighed heavily on biotech stocks. Credit ...
Read Full Story »
131772836

The Highest-Yielding Dividends That Are Safe to Hold

The number of companies paying dividends in the S&P 500 is at a 15-year high. According to FactSet, just over 80 companies in the index do not pay dividends. Paying ...
Read Full Story »